Dow Jones

40 614,31

1,00%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
BioPlus Acquisition Corporation (BIOS)
BioPlus Acquisition Corporation (BIOS) Actualités

BIOS

BioPlus Acquisition (BIOS)

BioPlus Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:BIOS

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
04/10/2023	13h30	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	NASDAQ:BIOS	BioPlus Acquisition Corporation
04/10/2023	13h30	GlobeNewswire Inc.	Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination	NASDAQ:BIOS	BioPlus Acquisition Corporation
16/08/2023	14h30	GlobeNewswire Inc.	Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring	NASDAQ:BIOS	BioPlus Acquisition Corporation
17/07/2023	14h00	GlobeNewswire Inc.	Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors	NASDAQ:BIOS	BioPlus Acquisition Corporation
13/06/2023	14h30	GlobeNewswire Inc.	Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando	NASDAQ:BIOS	BioPlus Acquisition Corporation
03/05/2023	14h30	GlobeNewswire Inc.	Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/12/2021	14h00	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOS	BioPlus Acquisition Corporation
03/02/2020	14h30	GlobeNewswire Inc.	Option Care Health Completes Reverse Stock Split and Ticker Symbol Change	NASDAQ:BIOS	BioPlus Acquisition Corporation
26/12/2019	22h24	GlobeNewswire Inc.	RLH Corporation Appoints R. Carter Pate as Chairman	NASDAQ:BIOS	BioPlus Acquisition Corporation
18/12/2019	15h22	GlobeNewswire Inc.	Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/12/2019	14h00	GlobeNewswire Inc.	Daniel E. Greenleaf Appointed as Chief Executive Officer of The Providence Service Corporation and LogistiCare	NASDAQ:BIOS	BioPlus Acquisition Corporation
21/11/2019	16h39	GlobeNewswire Inc.	Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation
19/11/2019	20h14	GlobeNewswire Inc.	Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment	NASDAQ:BIOS	BioPlus Acquisition Corporation
06/11/2019	12h00	GlobeNewswire Inc.	Option Care Health Announces Third Quarter Results	NASDAQ:BIOS	BioPlus Acquisition Corporation
16/10/2019	22h05	GlobeNewswire Inc.	Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call	NASDAQ:BIOS	BioPlus Acquisition Corporation
30/08/2019	00h05	Business Wire	Option Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference	NASDAQ:BIOS	BioPlus Acquisition Corporation
27/08/2019	22h01	GlobeNewswire Inc.	Kathryn Stalmack appointed as SVP, General Counsel and Corporate Secretary of Providence Service Corporation and LogistiCare	NASDAQ:BIOS	BioPlus Acquisition Corporation
13/08/2019	23h00	Business Wire	Option Care Health Receives Anticipated Nasdaq Notice	NASDAQ:BIOS	BioPlus Acquisition Corporation
07/08/2019	14h00	Business Wire	Option Care and BioScrip Complete Merger to Form Option Care Health	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/08/2019	18h40	GlobeNewswire Inc.	BioScrip Announces Shareholder Approval of Merger with Option Care	NASDAQ:BIOS	BioPlus Acquisition Corporation
30/07/2019	14h00	GlobeNewswire Inc.	BioScrip Reports Second Quarter 2019 Financial Results	NASDAQ:BIOS	BioPlus Acquisition Corporation
22/07/2019	15h00	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transa...	NASDAQ:BIOS	BioPlus Acquisition Corporation
24/06/2019	15h29	GlobeNewswire Inc.	LogistiCare Announces Leadership Transition	NASDAQ:BIOS	BioPlus Acquisition Corporation
13/06/2019	15h00	GlobeNewswire Inc.	Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Ca...	NASDAQ:BIOS	BioPlus Acquisition Corporation
10/06/2019	17h47	GlobeNewswire Inc.	RLH Corporation Announces Changes to Its Board of Directors	NASDAQ:BIOS	BioPlus Acquisition Corporation
21/05/2019	15h00	GlobeNewswire Inc.	BioScrip to Participate in Upcoming Investor Conferences	NASDAQ:BIOS	BioPlus Acquisition Corporation
02/05/2019	13h00	GlobeNewswire Inc.	BioScrip Reports First Quarter 2019 Financial Results	NASDAQ:BIOS	BioPlus Acquisition Corporation
23/04/2019	15h00	GlobeNewswire Inc.	BioScrip, Inc. Provides Merger Update	NASDAQ:BIOS	BioPlus Acquisition Corporation
15/03/2019	12h01	GlobeNewswire Inc.	BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results	NASDAQ:BIOS	BioPlus Acquisition Corporation
15/03/2019	12h00	GlobeNewswire Inc.	Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge	NASDAQ:BIOS	BioPlus Acquisition Corporation